Regenxbio IncNASDAQ:RGNX
- LAST PRICE15.8000
- TODAY'S CHANGE (%)0.0600 (0.3812%)
- Bid / Lots14.5000/ 3
- Ask / Lots16.7500/ 1
- Open / Previous Close15.8900 / 15.7400
- Day Range
- 52 Week Range
- Volume369,317
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RGNX |
|---|---|---|
| 09:32 ET | 7932 | 15.88 |
| 09:34 ET | 1300 | 16.25 |
| 09:36 ET | 2200 | 16.16 |
| 09:38 ET | 272 | 16.09 |
| 09:39 ET | 600 | 16.09 |
| 09:43 ET | 400 | 15.96 |
| 09:45 ET | 300 | 15.92 |
| 09:50 ET | 200 | 15.805 |
| 09:52 ET | 200 | 15.775 |
| 09:54 ET | 5700 | 15.695 |
| 09:57 ET | 781 | 15.69 |
| 09:59 ET | 300 | 15.655 |
| 10:03 ET | 758 | 15.64 |
| 10:06 ET | 200 | 15.6 |
| 10:08 ET | 3653 | 15.68 |
| 10:10 ET | 1196 | 15.69 |
| 10:12 ET | 100 | 15.63 |
| 10:15 ET | 416 | 15.61 |
| 10:17 ET | 1100 | 15.64 |
| 10:21 ET | 1000 | 15.61 |
| 10:24 ET | 400 | 15.605 |
| 10:26 ET | 700 | 15.62 |
| 10:28 ET | 300 | 15.63 |
| 10:30 ET | 1237 | 15.65 |
| 10:32 ET | 3220 | 15.66 |
| 10:35 ET | 508 | 15.66 |
| 10:37 ET | 200 | 15.665 |
| 10:39 ET | 2011 | 15.655 |
| 10:42 ET | 200 | 15.69 |
| 10:44 ET | 1300 | 15.66 |
| 10:46 ET | 238 | 15.675 |
| 10:50 ET | 1300 | 15.74 |
| 10:51 ET | 500 | 15.785 |
| 10:53 ET | 709 | 15.85 |
| 10:55 ET | 1201 | 15.84 |
| 10:57 ET | 200 | 15.9 |
| 11:00 ET | 100 | 15.885 |
| 11:02 ET | 410 | 15.835 |
| 11:04 ET | 100 | 15.82 |
| 11:08 ET | 500 | 15.76 |
| 11:13 ET | 500 | 15.8 |
| 11:15 ET | 100 | 15.78 |
| 11:18 ET | 100 | 15.765 |
| 11:20 ET | 300 | 15.74 |
| 11:22 ET | 215 | 15.76 |
| 11:24 ET | 800 | 15.8 |
| 11:26 ET | 100 | 15.79 |
| 11:27 ET | 220 | 15.81 |
| 11:31 ET | 805 | 15.8 |
| 11:33 ET | 1085 | 15.8418 |
| 11:38 ET | 100 | 15.85 |
| 11:40 ET | 6959 | 15.9997 |
| 11:42 ET | 300 | 15.965 |
| 11:44 ET | 800 | 15.9345 |
| 11:45 ET | 217 | 15.95 |
| 11:47 ET | 500 | 15.95 |
| 11:49 ET | 100 | 15.95 |
| 11:51 ET | 200 | 15.94 |
| 11:54 ET | 1526 | 15.835 |
| 11:58 ET | 600 | 15.82 |
| 12:00 ET | 464 | 15.82 |
| 12:02 ET | 100 | 15.83 |
| 12:03 ET | 100 | 15.83 |
| 12:05 ET | 100 | 15.83 |
| 12:07 ET | 400 | 15.805 |
| 12:09 ET | 500 | 15.84 |
| 12:12 ET | 100 | 15.8 |
| 12:14 ET | 600 | 15.81 |
| 12:16 ET | 100 | 15.815 |
| 12:18 ET | 100 | 15.8 |
| 12:20 ET | 100 | 15.795 |
| 12:21 ET | 1823 | 15.79 |
| 12:23 ET | 1500 | 15.86 |
| 12:25 ET | 200 | 15.87 |
| 12:27 ET | 100 | 15.845 |
| 12:30 ET | 100 | 15.84 |
| 12:36 ET | 400 | 15.85 |
| 12:39 ET | 300 | 15.87 |
| 12:43 ET | 200 | 15.87 |
| 12:45 ET | 1400 | 15.86 |
| 12:48 ET | 100 | 15.85 |
| 12:50 ET | 800 | 15.87 |
| 12:54 ET | 100 | 15.85 |
| 12:57 ET | 708 | 15.81 |
| 01:01 ET | 377 | 15.795 |
| 01:03 ET | 2050 | 15.82 |
| 01:08 ET | 300 | 15.83 |
| 01:10 ET | 100 | 15.79 |
| 01:12 ET | 300 | 15.79 |
| 01:14 ET | 900 | 15.77 |
| 01:17 ET | 908 | 15.79 |
| 01:19 ET | 300 | 15.81 |
| 01:21 ET | 100 | 15.76 |
| 01:24 ET | 700 | 15.81 |
| 01:30 ET | 100 | 15.84 |
| 01:32 ET | 400 | 15.87 |
| 01:35 ET | 3053 | 15.96 |
| 01:37 ET | 426 | 15.919 |
| 01:39 ET | 100 | 15.94 |
| 01:42 ET | 300 | 15.935 |
| 01:44 ET | 500 | 15.95 |
| 01:48 ET | 100 | 15.96 |
| 01:50 ET | 1000 | 15.94 |
| 01:51 ET | 200 | 15.92 |
| 01:53 ET | 2777 | 15.83 |
| 01:57 ET | 500 | 15.845 |
| 02:00 ET | 100 | 15.82 |
| 02:02 ET | 4135 | 15.885 |
| 02:04 ET | 550 | 15.91 |
| 02:11 ET | 1008 | 15.925 |
| 02:13 ET | 434 | 15.87 |
| 02:15 ET | 200 | 15.9 |
| 02:18 ET | 744 | 15.92 |
| 02:20 ET | 400 | 15.9 |
| 02:22 ET | 441 | 15.89 |
| 02:24 ET | 100 | 15.865 |
| 02:26 ET | 200 | 15.845 |
| 02:27 ET | 3778 | 15.85 |
| 02:29 ET | 300 | 15.83 |
| 02:33 ET | 1150 | 15.835 |
| 02:36 ET | 500 | 15.815 |
| 02:38 ET | 500 | 15.81 |
| 02:40 ET | 541 | 15.75 |
| 02:42 ET | 600 | 15.74 |
| 02:45 ET | 600 | 15.74 |
| 02:47 ET | 1442 | 15.76 |
| 02:49 ET | 100 | 15.78 |
| 02:51 ET | 100 | 15.75 |
| 02:54 ET | 1007 | 15.84 |
| 02:56 ET | 100 | 15.84 |
| 02:58 ET | 500 | 15.827 |
| 03:00 ET | 1500 | 15.84 |
| 03:02 ET | 250 | 15.835 |
| 03:03 ET | 600 | 15.82 |
| 03:07 ET | 1479 | 15.846 |
| 03:09 ET | 400 | 15.85 |
| 03:12 ET | 400 | 15.86 |
| 03:16 ET | 900 | 15.83 |
| 03:18 ET | 200 | 15.845 |
| 03:20 ET | 900 | 15.89 |
| 03:21 ET | 500 | 15.87 |
| 03:23 ET | 886 | 15.86 |
| 03:25 ET | 3931 | 15.8 |
| 03:27 ET | 1073 | 15.827 |
| 03:30 ET | 500 | 15.85 |
| 03:32 ET | 1829 | 15.8756 |
| 03:34 ET | 300 | 15.86 |
| 03:36 ET | 3063 | 15.84 |
| 03:38 ET | 1642 | 15.865 |
| 03:39 ET | 1700 | 15.86 |
| 03:41 ET | 5601 | 15.87 |
| 03:43 ET | 1400 | 15.89 |
| 03:45 ET | 1400 | 15.888 |
| 03:48 ET | 966 | 15.89 |
| 03:50 ET | 4243 | 15.87 |
| 03:52 ET | 6900 | 15.87 |
| 03:54 ET | 4224 | 15.89 |
| 03:56 ET | 9428 | 15.8745 |
| 03:57 ET | 4169 | 15.82 |
| 03:59 ET | 5671 | 15.8 |
May 10, 2024
REGENXBIO to Participate in Upcoming Investor Conferences, from 7:05AM ET on Friday May 10, 2024 by Dow Jones
7:05AM ET on Friday May 10, 2024 by Dow Jones
May 8, 2024
REGENXBIO Reports First Quarter 2024 Financial Results and Recent Operational Highlights, from 4:05PM ET on Wednesday May 08, 2024 by Dow Jones
4:05PM ET on Wednesday May 08, 2024 by Dow Jones*DJ REGENXBIO 1Q Loss/Shr $1.38 >RGNX, from 4:05PM ET on Wednesday May 08, 2024 by Dow Jones
4:05PM ET on Wednesday May 08, 2024 by Dow Jones
May 1, 2024
REGENXBIO to Host Conference Call on May 8 to Discuss First Quarter 2024 Financial Results and Recent Operational Highlights, from 7:05AM ET on Wednesday May 01, 2024 by Dow Jones
7:05AM ET on Wednesday May 01, 2024 by Dow Jones
Apr 24, 2024
REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit, from 7:05AM ET on Wednesday Apr 24, 2024 by Dow Jones
7:05AM ET on Wednesday Apr 24, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Regenxbio Inc | 771.9M | -2.7x | --- |
SAGE Therapeutics Inc | 732.1M | -1.4x | --- |
Nurix Therapeutics Inc | 826.7M | -5.6x | --- |
Zymeworks Inc | 653.3M | -5.0x | --- |
WAVE Life Sciences Ltd | 696.0M | -11.3x | --- |
CureVac NV | 666.2M | -2.4x | --- |
Company Information
REGENXBIO Inc. is a clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. The Company has developed a pipeline of gene therapy programs using its proprietary adeno-associated virus (AAV) gene therapy delivery platform (NAV Technology Platform) to address genetic diseases. The Company is focused on its internal development pipeline in three areas: retinal, neuromuscular and neurodegenerative diseases. Its investigational AAV therapeutics include ABBV-RGX-314, RGX-202 and RGX-121. It is developing ABBV-RGX-314 in collaboration with AbbVie to treat large patient populations impacted by wet age-related macular degeneration, diabetic retinopathy (DR) and other chronic retinal diseases characterized by loss of vision. It is developing RGX-202 to treat Duchenne muscular dystrophy (Duchenne). The Company is developing RGX-121 to treat Mucopolysaccharidosis type II (MPS II), a progressive, neurodegenerative lysosomal storage disorder.
Contact Information
- Headquarters
- 9804 Medical Center DriveROCKVILLE, MD, United States 20850
- Phone
- 240-552-8181
- Fax
- 302-655-5049
Executives
- Chairman of the Board
- Allan Fox
- President, Chief Executive Officer, Director
- Kenneth Mills
- Chief Financial Officer, Executive Vice President
- Vittal Vasista
- Chief Operating Officer, Executive Vice President
- Curran Simpson
- Executive Vice President, Chief Scientific Officer
- Olivier Danos
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $771.9M |
|---|---|
Revenue (TTM) | $86.7M |
Shares Outstanding | 49.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.36 |
EPS | $-5.88 |
Book Value | $7.08 |
P/E Ratio | -2.7x |
Price/Sales (TTM) | 8.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -306.52% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
